FRAMINGHAM, Mass. and
SYDNEY, July 19, 2013 /PRNewswire/ -- HeartWare
International, Inc. (NASDAQ:HTWR, ASX:HIN) has scheduled a
conference call to discuss its financial results for the three
months ended June 30, 2013, at
8:00 a.m. U.S. Eastern Daylight Time
on Thursday, August 8, 2013. The
Company plans to release the financial results prior to the
conference call.
The conference call with management will discuss the Company's
financial results, highlights from the second quarter and business
outlook. The call may be accessed by dialing 1-877-941-2321
five minutes prior to the scheduled start time and referencing
"HeartWare." For callers outside the U.S., please dial
+1-480-629-9666.
A live webcast of the call will also be available in the
Investor section at the Company's website
(http://ir.heartware.com/). A replay of the conference call will be
available through the above weblink immediately following
completion of the call.
A copy of the news release announcing results and related
information will be available on the Company's website,
www.heartware.com.
About HeartWare International
HeartWare International develops and manufactures miniaturized
implantable heart pumps, or ventricular assist devices, to treat
Class IIIB / IV patients suffering from advanced heart failure. The
HeartWare® Ventricular Assist System features the HVAD® pump, a
small full-support circulatory assist device designed to be
implanted next to the heart, avoiding the abdominal surgery
generally required to implant competing devices. The HeartWare
System is approved in the United
States for the intended use as a bridge to cardiac
transplantation in patients who are at risk of death from
refractory end-stage left ventricular heart failure, has received
CE Marking in the European Union and has been used to treat
patients in 30 international countries. The device is also
currently the subject of a U.S. clinical trial for destination
therapy. For additional information, please visit the Company's
website at www.heartware.com.
HeartWare International, Inc. is a member of the Russell
2000® and its securities are publicly traded on The
NASDAQ Stock Market and the Australian Securities Exchange.
HEARTWARE, HVAD, MVAD and HeartWare logos are registered
trademarks of HeartWare, Inc.
For further information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartwareinc.com
Phone: +1 508 739 0864
SOURCE HeartWare International, Inc.